Nocion Therapeutics Appoints Matthew as Chief Medical Officer
28 Apr 2025 //
BUSINESSWIRE
Nocion Doses 1st Patient in ASPIRE Ph 2b Chronic Cough Study
18 Nov 2024 //
BUSINESSWIRE
Nocion Shares Taplucainium Data For Chronic Cough At London Symposium
15 Jul 2024 //
BUSINESSWIRE
Nocion Therapeutics Adds Dr. Bonuccelli To Board, Shaw To Clinical Ops
08 Jul 2024 //
BUSINESSWIRE
Nocion Therapeutics Announces $62 Million Series B Financing
04 Mar 2024 //
BUSINESSWIRE
Nocion Therapeutics Announces Dosing Underway in Participants with Chronic Cough
31 Aug 2021 //
BUSINESSWIRE